ChromaDex Q2 sales drop
ChromaDex’s net loss was $1.84m, compared to $303,529 for the same period in the prior year. The company’s operating loss was $1.83m for the second quarter ended July
Biointron Biological has launched RushData, a new platform to support the process of antibody discovery for pharmaceutical and biotechnology companies employing AI and machine learning (ML).